Shīrāz, Iran, Islamic Republic of
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Phase
3Span
219 weeksSponsor
Hoffmann-La RocheBattipaglia, Campania
Recruiting
1-1 of 1